Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Liver cancer, Secondary cancers
Closed
Phase 1/2
This study is looking at MIV-818 in combination with lenvatinib or pembrolizumab for people with .
Recruitment start: 5 September 2018
Recruitment end: 31 August 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Ruth Plummer
Medivir
Last reviewed: 29 December 2023
CRUK internal database number: 16921
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
